Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
      QxMD      Google Scholar   
Citation:
Ann Oncol vol 19 (5) 946-950
Year:
2008
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                   
Networks:
 
Study
CALGB-90207
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: